Role of colony-stimulating factors in atherosclerosis

Karina Di Gregoli1, Jason L Johnson

  • 1Laboratory of Cardiovascular Pathology, School of Clinical Sciences, University of Bristol, Bristol Royal Infirmary, Bristol, UK.

Insights

Colony-stimulating factors (CSFs) create diverse macrophage populations influencing lipid processing and inflammation. Understanding CSF-driven macrophage heterogeneity is key to halting atherosclerosis progression and plaque rupture.

Area of Science:

  • Cardiovascular Research
  • Immunology
  • Cell Biology

Background:

  • Colony-stimulating factors (CSFs) influence monocyte and macrophage behavior.
  • Macrophage heterogeneity plays a role in inflammation and atherosclerosis.
  • Understanding CSF effects is crucial for managing cardiovascular disease.

Purpose of the Study:

  • To investigate whether differing effects of CSFs dictate macrophage function and disease progression in atherosclerosis.
  • To explore the role of CSFs in macrophage heterogeneity and its impact on atherogenesis.

Main Methods:

  • Review of existing literature on CSFs, macrophages, and atherosclerosis.
  • Analysis of molecular markers and genomic signatures associated with CSF-driven macrophage phenotypes.
  • Examination of CSF levels as potential biomarkers for disease progression.

Main Results:

  • CSFs generate heterogeneous monocyte-derived macrophages with distinct lipid processing and inflammatory capabilities.
  • CSFs are present in atherosclerotic plaques and circulation, potentially serving as predictive biomarkers.
  • Differential CSF exposure leads to divergent macrophage genomic signatures and functional properties, impacting atherogenesis.

Conclusions:

  • Macrophage heterogeneity is critical in atherosclerosis development and progression.
  • Identifying consistent markers for specific macrophage subsets is an active area of research.
  • Further understanding of CSF regulation of macrophage phenotypes is needed for targeted therapeutic interventions against atherosclerosis.
Abstract

Related Concept Videos

Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
Inflammation01:38

Inflammation

Overview
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...